Andere talen Willow Biosciences Inc.

Aandelen

WLLW

CA97111B4047

slotkoers Toronto S.E. Andere beurzen 00:00:00 21-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,105 ^CAD	+10,53%		+5,00%	+5,00%

30/05	Willow Biosciences Inc. Kondigt een multi-productontwikkelings- en licentiepartnerschap met Laurus Labs aan	CI
13/05	Willow Biosciences Inc. Geeft winstverwachting voor het boekjaar 2024	CI

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

Willow Bioscience Announces 3 Million dollar Fundraising to Support Partnership with Laurus Labs	07/06
Willow Biosciences to Raise Up to $3 Million Via Brokered Private Placement; Shares Jumped 24% on Friday	03/06
Willow Biosciences Brief: Announcing Brokered Private Placement Offering To Raise Up To $3 Million	03/06
WILLOW ANNOUNCES BROKERED PRIVATE PLACEMENT OFFERING TO RAISE UP TO $3.0 MILLION	03/06
Willow Biosciences Inc. announced that it expects to receive CAD 3 million in funding	03/06
Willow Biosciences Signs Multi-Product Development, Licensing Partnership With Laurus Lab	30/05
Willow Biosciences Brief: Announcing Multi-product Development and Licensing Partnership With Laurus Lab	30/05
Willow Biosciences Inc. Announces Multi-Product Development and Licensing Partnership with Laurus Labs	30/05
WILLOW ANNOUNCES MULTI-PRODUCT DEVELOPMENT AND LICENSING PARTNERSHIP WITH LAURUS LABS FOR MANUFACTURING ACTIVE PHARMACEUTICAL INGREDIENTS	30/05
Willow Biosciences Brief: Reiterating its Expectations of at least doubling its full year 2024 revenues, As Reports Q1 Results	13/05
Willow Biosciences Inc. Provides Earnings Guidance for the Fiscal Year 2024	13/05
Willow Biosciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	13/05
Willow Biosciences Narrows 2023 Loss YOY	01/04
Willow Biosciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	29/03
WILLOW BIOSCIENCES REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIALS AND OPERATIONS AND FILING OF ITS 2023 AIF	29/03
Willow Biosciences Announces Second Strategic Investment From Kalsec	01/03
Willow Biosciences Secures Strategic Investment From Kalsec to Develop Natural Food Ingredient	21/02
Willow Biosciences Inc. announced that it expects to receive funding from Kalsec Inc.	20/02
Willow Biosciences Enters Partnership With Global Ingredient Manufacturer	31/01
Willow Biosciences Inc. Announces Collaboration with Global Active Pharmaceutical Ingredient Manufacturer to Develop A More Sustainable, Cost-Effective Manufacturing Process for A Large Volume Global Market	31/01

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Willow Biosciences Inc.

Aandelen

WLLW

CA97111B4047

Andere talen

Filters